Dopamine Precursors
Treatment with levodopa is associated with impulse control disorders including pathological gambling, binge eating and hypersexuality. Patients and their carers should be warned of the risk and if impulse control disorders develop levodopa should be withdrawn or the dose reduced until the symptoms resolve.
NICE guidance
TA934 Foslevodopa–foscarbidopa for treating advanced Parkinson’s with motor symptoms, November 2023: No centres within Kent and Medway are commissioned to provide this - via tertiary services only.
NG71 Parkinson's disease in adults, July 2017
Calculator for inpatients who cannot take their usual oral Parkinson's medication orally - guidance for switching to liquid/dispersible preparations and/or patches if needed
Modified release capsules are useful for "end of dose" fluctuations and nocturnal immobility or rigidity.
| Pack |
|---|
| 100 capsule |
| 30 capsule |
| 60 capsule |
| Pack |
|---|
| 100 capsule |
| Pack |
|---|
| 100 capsule |
| Pack |
|---|
| 100 capsule |
| Pack |
|---|
| 100 tablet |
| Pack |
|---|
| 100 tablet |
| 30 tablet |
| 60 tablet |
| Pack |
|---|
| 100 tablet |
| 50 tablet |
| 60 tablet |
| Pack |
|---|
| 30 tablet |
| 50 tablet |
| 60 tablet |
| Pack |
|---|
| 90 tablet |
| Pack |
|---|
| 100 tablet |
| 90 tablet |
| Pack |
|---|
| 100 tablet |
| 30 tablet |
| 50 tablet |
| 60 tablet |
| 90 tablet |
| Pack |
|---|
| 100 tablet |
| 50 tablet |
| 90 tablet |
- On Formulary Preferred
- On Formulary Second Line
- On Formulary Third Line
- Specialist Initiation
- Secondary Care Only
- Not Approved for Formulary